|
End-of-day quote
Shenzhen S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 9.910 CNY | +1.95% |
|
+1.95% | -8.66% |
| Market Cap | 5.06B 755M 675M 629M 572M 1.08B 73.03B 1.08B 7.56B 2.95B 37.14B 2.83B 2.77B 119B | P/E 2024 |
224x | P/E 2025 | 67.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.99B 744M 665M 620M 563M 1.06B 71.98B 1.07B 7.45B 2.91B 36.61B 2.79B 2.73B 118B | EV / Sales 2024 |
6.57x | EV / Sales 2025 | 5.78x |
| Free-Float |
59.54% | Yield 2024 |
0.56% | Yield 2025 | 1.38% |
| 1 day | +1.95% | ||
| 1 week | +1.95% | ||
| 1 month | +10.48% | ||
| 3 months | +3.99% | ||
| 6 months | -9.91% | ||
| Current year | -8.66% |
| 1 month | 8.96 |  | 10.15 |
| Current year | 7.66 | | 14.47 |
| 1 year | 7.66 | | 15.21 |
| 3 years | 6.79 | | 17.49 |
| 5 years | 5.64 | | 19.64 |
| 10 years | 5.01 | | 20.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rong Huang Xu
CEO | Chief Executive Officer | 34 | 16/07/2025 |
Xi Liang Chen
DFI | Director of Finance/CFO | 54 | 15/06/2009 |
Ru Qing Yao
PRN | Corporate Officer/Principal | 43 | 01/06/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Xi Liang Chen
BRD | Director/Board Member | 54 | 15/06/2009 |
Bei Jing Lu
BRD | Director/Board Member | 43 | 27/06/2022 |
Rong Huang Xu
CHM | Chairman | 34 | 16/07/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/7/24 A | Buy | Chief Financial Officer | 42,000 | 0.0188% | ||
| 6/14/23 A | Buy | Chief Financial Officer | 42,000 | 0.0188% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.95% | +1.95% | +15.10% | -10.20% | 755M | |
| +2.70% | +2.73% | +40.91% | +110.31% | 1,060B | |
| +1.44% | -2.38% | +36.83% | +63.95% | 623B | |
| +1.75% | +3.73% | +16.55% | +83.05% | 480B | |
| +0.60% | -1.73% | +62.98% | +37.46% | 352B | |
| -1.50% | +1.26% | +21.32% | +40.88% | 345B | |
| -1.12% | +0.39% | +11.29% | +34.48% | 274B | |
| -1.05% | -1.97% | -5.81% | +10.89% | 249B | |
| +2.60% | -2.00% | +39.77% | +54.44% | 223B | |
| +1.82% | -1.48% | +25.75% | +96.48% | 182B | |
| Average | -0.23% | -0.36% | +26.47% | +52.17% | 378.88B | |
| Weighted average by Cap. | -0.33% | +0.04% | +31.40% | +70.13% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 688M 103M 91.66M 85.51M 77.67M 146M 9.92B 147M 1.03B 401M 5.05B 385M 377M 16.22B | 925M 138M 123M 115M 104M 197M 13.34B 198M 1.38B 540M 6.78B 518M 506M 21.81B |
| Net income | 20.5M 3.06M 2.73M 2.55M 2.31M 4.36M 296M 4.39M 30.62M 11.96M 150M 11.48M 11.23M 483M | 81.67M 12.18M 10.88M 10.15M 9.22M 17.37M 1.18B 17.5M 122M 47.67M 599M 45.73M 44.74M 1.93B |
| Net Debt | 58.68M 8.75M 7.82M 7.3M 6.63M 12.48M 847M 12.57M 87.67M 34.25M 431M 32.86M 32.15M 1.38B | -72.61M -10.83M -9.68M -9.03M -8.2M -15.44M -1.05B -15.56M -108M -42.38M -533M -40.66M -39.78M -1.71B |
Employees
1,434
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | CN¥9.910 | +1.95% | 19,431,596 |
| 29/09/26 | CN¥9.720 | +0.52% | 15,743,319 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002728 Stock
Select your edition
All financial news and data tailored to specific country editions
